The results demonstrated that TF-targeting CAR1-NK cells inhibited orthotopic PDX growth in mice as measure by tumor volume (p < 0.0001, 93.7% reduction as compared to control tumor on day 22 after initiation of treatment) (Fig. 5A). This evidence concerns the gene TF and neoplasm.